Economy

What Does Insider Trading Tell Us About PAREXEL International Corporation (PRXL)?

PAREXEL International Corporation (NASDAQ:PRXL) reported its EPS in the last quarter as $1.02/Share beating the analyst estimate of $0.93/Share by a difference of $0.09. Meadow Creek Investment Management LLC now owns 1,980 shares of the medical research company's stock worth $125,000 after acquiring an additional 132 shares in the last quarter. The institutional investor owned 370,138 shares of the medical research company's stock after acquiring an additional 111,691 shares during the quarter.

According to PAREXEL International Corporation's latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 0%.

A number of other institutional investors also recently modified their holdings of the stock. Amalgamated Bank increased its stake in PAREXEL International Corporation by 0.6% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in PAREXEL International Corporation by 10.0% in the second quarter. Texas Permanent School Fund increased its stake in PAREXEL International Corporation by 0.5% during the 2nd quarter. Finally, Cowen Inc. acquired a new stake in shares of PAREXEL International Corporation in the 2nd quarter worth about $7,886,000. The correct version of this piece can be viewed at https://stocknewstimes.com/2017/10/02/halcyon-management-partners-lp-purchases-new-position-in-parexel-international-corporation-prxl.html.

PRXL has been the subject of several analyst reports. Zacks Investment Research upgraded PAREXEL International Corporation from a "hold" rating to a "buy" rating and set a $98.00 price objective for the company in a report on Thursday, August 31st. BidaskClub downgraded shares of PAREXEL International Corporation from a "strong-buy" rating to a "buy" rating in a report on Friday, July 28th.

PAREXEL International Corporation (NASDAQ:PRXL) touched its 1-Year High price of $88.10 on 09/29/17 and its 1-Year Low price of $51.16 on 11/11/16.

The price target set for the stock is $86.71 and this sets up an interesting set of potential movement for the stock, according to data from Finviz's Research. Raymond James Financial, Inc. upgraded PAREXEL International Corporation from an "underperform" rating to a "mkt perform" rating in a research note on Tuesday, June 20th.

Analysts have given a mean recommendation of 3.00 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range).

The average Wall Street analyst rating for PAREXEL International Corporation is Hold, according to the average of 14 analyst scores. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of USA & global copyright & trademark legislation. The company's stock had a trading volume of 7,021,106 shares.

PAREXEL International Corporation (NASDAQ:PRXL) closed its last session at $88.08. The stock has a 50 day moving average of $87.74 and a 200 day moving average of $78.14. The co's performance for 6 months was isolated positively of 3.72%, 1-year performance stands at 52.45% and year to date showing moved up performance of 2.13%. The firm has a market capitalization of $4.50 billion, a P/E ratio of 42.76 and a beta of 0.77.

PAREXEL International Corporation (NASDAQ:PRXL) last announced its earnings results on Monday, August 28th. It has a return on equity (ROE) of 17.70%.

Celldex Therapeutics, Inc. (CLDX) revenue scored -31.37% growth from the previous quarter, coming up with $1.05 million.

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. Whereas, in last 21 trading days (one month) was climbed 8.17% and moved down in last 63 trading days (quarter) of -0.37%. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services.



Like this

Latest


02 October 2017
Wimbledon station commuters flee train in 'Bible' panic
This has caused significant delays to services in and out of Waterloo that will continue for the rest of the morning. Some people on the train suggested the panic had been cause by other passengers mishearing what the man was saying.

02 October 2017
Nissan Leaf Nismo concept heads to Tokyo
The second edition of the electrified NV200 van will provide customers with an extra 62 miles in range, offering 174 miles on a single charge.

02 October 2017
'The Simpsons' meets 'Game of Thrones' in this season premiere sneak peek
But when Lisa's actions result in her kidnapping, Homer is forced to mount a feudal uprising in a bid to secure her safe return. This Sunday's Simpsons season premiere was a Game of Thrones parody, but the episode ended in Springfield instead of Westeros.

02 October 2017
Sean Maguire and Scott Hogan in Ireland's final World Cup qualifier squad
They will undergo three more sessions there ahead of the game against Moldova at Aviva Stadium on Friday, October 6. The 32-year-old has not played since being hurt in a Championship match against Burton Albion in August.

02 October 2017
Boston Scientific Corporation (NYSE:BSX) Traded Higher Than Its 50 Day Average
State Street Corp decreased its stake in Verisign Inc (VRSN) by 2.21% based on its latest 2017Q2 regulatory filing with the SEC. The United Services Automobile Association holds 1.12 million shares with $31.03 million value, up from 996,251 last quarter.

02 October 2017
Petrol price to rise on Wednesday
If you weren't feeling it already, get ready for a financial pinch because an increase in the petrol price has been confirmed. The Energy Department confirmed on Monday that petrol, diesel and paraffin will all see a price increase from 4 October.

02 October 2017
HTC Vive Fallout 4 VR bundle available now
It's full-priced - £40 - but not due until 12th December so HTC will give you a redemption code for it. If you've been on the fence about buying a VR headset, as in, you're still not sure which one to buy.

02 October 2017
Dalit man beaten to death for attending Garba in Gujarat
The accused made casteist remarks and asked some men to come to the spot, said an officer at the Bhadran police station. Thereafter, the Patel men allegedly beat up the Dalits, banging Solanki's head against a wall.

02 October 2017
Police Arrest Tulsa Juvenile For Murder, Armed Robbery And Sexual Assault
Police say it all started Sunday morning, when officers were called to an armed robbery in the 6500 block of East 71st Street. A man was shot and killed in front of his family Sunday afternoon as he confronted an armed robber during a home invasion.

02 October 2017
Kennedy gets home win as Royals top Arizona 2-1
Chris Iannetta also homered in the second inning as the Diamondbacks finished with 220 home runs, a season franchise record. Then I picked up my daughter from school and we made the two-and-a-half-hour drive from Jefferson City to The K.



Recommended